These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 113218

  • 1. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B, Einarsson K, Leijd B.
    Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
    [Abstract] [Full Text] [Related]

  • 2. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L, Olsson AG, Rössner S, Carlson LA.
    Postgrad Med J; 1975 Jun; 51(8):suppl 76-81. PubMed ID: 215986
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipid lowering drugs and hyperlipidaemia.
    Levy RI, Rifking BM.
    Drugs; 1973 Jun; 6(1):12-45. PubMed ID: 4361281
    [No Abstract] [Full Text] [Related]

  • 7. [Hyperlipoproteinemia].
    Meinders AE.
    Ned Tijdschr Geneeskd; 1979 Mar 14; 123(15):617-28. PubMed ID: 219378
    [No Abstract] [Full Text] [Related]

  • 8. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA, Heimann KW.
    S Afr Med J; 1975 Jul 19; 49(31):1252-6. PubMed ID: 168650
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid.
    Angelin B, Einarsson K, Leijd B.
    Eur J Clin Invest; 1981 Jun 19; 11(3):185-9. PubMed ID: 6791937
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
    Lehtonen A, Viikari J.
    Acta Med Scand; 1977 Jun 19; 202(3):179-81. PubMed ID: 333869
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of cholestyramine on tissue pools of cholesterol a preliminary report.
    Kudchodkar BJ, Sodhi HS, Horlick L, Nazir DJ.
    Proc Soc Exp Biol Med; 1975 Feb 19; 148(2):393-6. PubMed ID: 1121487
    [Abstract] [Full Text] [Related]

  • 20. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
    Turley SD, Dietschy JM.
    J Cardiovasc Pharmacol; 1980 Feb 19; 2(3):281-97. PubMed ID: 6156326
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.